Peginterferon alfa-2a (40 KD) (Pegasys) in combination with ribavirin (RBV): efficacy and safety results from a phase III, randomized, double-blind, multicentre study examining effect of duration of treatment and RBV dose - Hadziyannis,S.J.; Cheinquer,H.; Morgan,T. (J Hepatol, 2002)